Skip to content

Director’s Updates From 2006

NIMH Grantee Among First Recipients of K99/R00 Award

New investigator Bing Ye, Ph.D., University of California San Francisco, is among the first recipients of the new K99/R00 awards, created as part of the NIH Roadmap to help establish the next generation of investigators.

Continue Reading…

NIMH Perspective on Antipsychotic Reimbursement: Using Results from the CATIE Cost Effectiveness Study

The recent publication (December 1, 2006, American Journal of Psychiatry) of the cost-effectiveness results from the National Institute of Mental Health (NIMH)-funded Clinical Antipsychotic Trials in Intervention Effectiveness (CATIE) has raised questions among advocates, families, and clinicians about reimbursement policies for antipsychotic medications.

Continue Reading…

Special Update from the Director: Fulfilling the Mission During the Lean Years

The National Institute of Mental Health (NIMH) is about to celebrate its 60th birthday.

Continue Reading…

Prestigious Lieber Prize for Research Awarded to Jeffrey A. Lieberman, M.D.

NIMH-funded researcher Jeffrey A. Lieberman, M.D., of Columbia University was awarded the Lieber Prize for Schizophrenia Research by the National Alliance for Research on Schizophrenia and Depression (NARSAD) at the group's annual gala dinner in October 2006. NARSAD is one of the largest donor-supported organizations that funds research on the brain and behavioral disorders.

Continue Reading…

NIMH Perspective on Treating Alzheimer’s Patients with Antipsychotic Medications

The recent publication of phase 1 results from the NIMH-funded Clinical Antipsychotic Trials in Intervention Effectiveness for Alzheimer's disease (CATIE-AD) in the New England Journal of Medicine provides new information about the use of several "atypical" antipsychotic medications for the treatment of psychotic symptoms in patients with Alzheimer's disease.

Continue Reading…

New Division Directors Come on Board at NIMH

Following comprehensive, national searches for candidates, NIMH recently welcomed three new leaders to head various research divisions.

Continue Reading…

Aaron Beck, Founder of Cognitive Therapy, Receives Coveted Lasker Award

Aaron T. Beck, M.D., Professor Emeritus of Psychiatry at the University of Pennsylvania, the founder of cognitive therapy, and a long-time NIMH grantee, was named the recipient of the prestigious Lasker Award for Clinical Medical Research on September 17, 2006.

Continue Reading…

Beatriz Luna Selected for the Presidential Early Career Award in Science and Engineering

The Presidential Early Career Awards for Scientists and Engineers (PECASE) Program recently honored 12 NIH researchers, including NIMH grantee Beatriz Luna, Ph.D., Associate Professor of Psychiatry and Psychology and Director of the Laboratory for Neurocognitive Development at the University of Pittsburgh.

Continue Reading…

Mental Health Research: Into the Future

In the six decades that NIMH has led the nation's research effort in mental health, advancement has been dramatic. We understand now that the major mental disorders are brain disorders, with specific symptoms rooted in abnormal patterns of brain activity.

Continue Reading…